Description
The University of New Mexico/Hospital is seeking to make a sole source purchase for the Y90 Therashere and catheter, a medical device used for minimally invasive radioembolization therapy for liver tumors. The device utilizes microscopic, insoluble glass beads containing yttrium-90 (Y-90), which are delivered via catheter directly to liver tumors to emit high-dose radiation. The proposed vendor is Boston Scientific, and the purchase amount is $300,000.00. The contract term is for 3 years with renewals.
• The Y90 Therashere and catheter is a proprietary item, technology, or service only available from Boston Scientific.
• The device is FDA-approved for the treatment of hepatocellular carcinoma (HCC) and other liver cancers.
• The university has conducted an extensive web search and was unable to find other possible sources for the device.
• The purchase is necessary for the university's radiology department to provide treatment for patients with liver tumors.